According to the Zhitong Finance APP, Oriental Ocean (002086.SZ) announced that its wholly-owned subsidiary Oriental Ocean Life Biotechnology Co., Ltd. ("Oriental Ocean Life Biotechnology") and Shandong Yinnu Medical Technology Co., Ltd. jointly invested in establishing: Shandong Oriental Hong Biotechnology Co., Ltd.; with a registered capital of 3 million yuan, the subsidiary needs to contribute 51% of the registered capital. In addition, Oriental Ocean Life Biotechnology and Fuzhou Yudi Trading Co., Ltd. jointly invested in establishing: Fuzhou Oriental Yudi Trading Co., Ltd.; with a registered capital of 2 million yuan, the subsidiary needs to contribute 51% of the registered capital.

It is reported that the establishment of the joint venture company this time aims to fully leverage the strengths of all parties, jointly build a product distribution platform and a terminal intensive platform with the cooperation partner, enhance the brand influence of the company's health products; leverage the cooperation partner's modern brand, sales channels to broaden the company's health product structure, rapidly promote the company's health self-product sales; rely on the cooperation partner's team to improve the company's health after-sales system; utilize the cooperation partner's resources to supplement the expert pool.